Computer model simulates cancer growth and treatment at nano scale

February 20, 2014 by Robyn Mills

(Medical Xpress)—A University of Adelaide PhD student has developed a computer model for simulating cancer tumour growth and treatment which is attracting interest from around the world as a first-line assessment of potential treatments.

The first of its kind in the world, the model simulates the growth of tumour from single cells and the effect of cancer treatments such as radiation at the nanoscale level.

"Unlike other cancer models, this model simulates the and effects of various treatments, right through to the probability of survival of cells and whether they have been destroyed by the treatment," says Michael Douglass, PhD student in the University's School of Chemistry and Physics.

The research, supervised by Associate Professor Eva Bezak, School of Chemistry and Physics and Chief Physicist, Royal Adelaide Hospital (RAH) and Dr Scott Penfold, Medical Physics Co-ordinator in the School, is currently focussed on radiotherapy.

"We model individual radiation particle interactions on scales smaller than the size of a water molecule," says Mr Douglass, who is also a medical physicist in the Department of Medical Physics at the RAH. We simulate the resultant biological damage to each cell in the tumour and how the cell repairs its DNA after being exposed to radiation."

The model is now being used to study new techniques such as the use of gold-nanoparticles to reduce the radiation dose needed to destroy tumours, and so reduce or eliminate acute radiation side-effects.

"Targeting and destroying an individual cancer cell in the human body is a bit like spotting a fly from several kilometres away," says Mr Douglass. "Since we can't see it, the only way to ensure the fly has been killed is to use a highly destructive nuclear weapon which results in huge collateral damage. When the fly starts to reproduce and becomes a huge swarm, then we can see it and take more precise action, but by that time the condition has become quite serious in terms of tumour growth and spread of the cancer."

"The beauty of this model is that we can investigate the actions of new treatments such as gold nano-particle therapy to see what happens when we can't look at it experimentally. The processes are happening on such a small scale that computer modelling is the only way of understanding how they are working.

"We can use the model to investigate what will happen with any therapy so we can verify it as a potential treatment and then, if it's looking promising, go ahead with clinical trials."

Over the next year, the model will be further developed in many international collaborations including Loma Linda University Medical Centre in the United States to study the effects of proton radiotherapy. It has also attracted the interest of NASA to study the effects of cosmic radiation on astronauts.

The model's algorithms also will be released to researchers around the world this year.

Explore further: Oxygen levels in tumours affect response to treatment

Related Stories

Oxygen levels in tumours affect response to treatment

November 7, 2013
(Medical Xpress)—The genetic make-up of a patient's tumour could be used to personalise their treatment, and help to decide whether they would benefit from receiving additional drugs as part of their radiotherapy programme, ...

Research discovers non–toxic cancer treatment

January 23, 2014
(Medical Xpress)—A University of Queensland researcher is developing a "Trojan horse" non-toxic treatment for human breast cancer.

Computer-controlled table could direct radiotherapy to tumours while sparing vital organs

December 18, 2013
Swivelling patients around on a computer-controlled, rotating table could deliver high doses of radiotherapy to tumours more quickly than current methods, while sparing vulnerable organs such as the heart, brain, eyes and ...

World first trial to improve prostate cancer care

November 28, 2013
Researchers and clinicians from the University of Sydney and the Northern Sydney Cancer Centre are leading a world first clinical trial using a tracking system to improve prostate cancer radiotherapy treatment.

Combination therapy could lead to reduction in prostate cancer recurrence

November 14, 2013
Prostate cancer patients who receive radiotherapy could soon be treated more effectively, according to research published today in the British Journal of Cancer.

Recommended for you

Vitamin C may encourage blood cancer stem cells to die

August 17, 2017
Vitamin C may "tell" faulty stem cells in the bone marrow to mature and die normally, instead of multiplying to cause blood cancers. This is the finding of a study led by researchers from Perlmutter Cancer Center at NYU Langone ...

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.